Northwestern Mutual Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Northwestern Mutual Wealth Management's BMY.RT Position: Q1 2021 in Review
Northwestern Mutual Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,041 shares — an estimated $7K sold.
Northwestern Mutual Wealth Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $43K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Northwestern Mutual Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 10,041 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
- Northwestern Mutual Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
- Northwestern Mutual Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $43K in Q4 2019.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2021, filed 14 May 2021.